Q3 results posts ups and downs in India pharma sector

Read more

New rules on compensation to make clinical trials in India ‘virtually impossible’: ISCR

Read more

Medicines Compendium expands global reach through new expert committees, enhanced website

Read more

Marck Biosciences takes private equity route with Tata Capital

Read more

Glenmark initiates IND enabling studies of novel monoclonal antibody targeting OX40

Read more

M&A activity in pharma sector focuses on expanding product offerings

Read more

STEM-2013 redefines stem cell research in India

Read more

GIPC-2013 sees congregation of IP experts

Read more

Bangalore INDIA BIO 2013 ends on a promising note

Read more

High Potent Drugs-2013 debates regulatory complexities

Read more